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THE ROLE OF α-ACIDIC GLYCOPROTEIN 
IN FORMATION OF BLEEDING ABNORMALITIES IN PATIENTS 
WITH MYELOPROLIFERATIVE NEOPLASMS
T.P. Nikolaenko-Kamyshova*
City Clinical Hospital № 4 of the Regional State Administration, Municipal Institution, Dnepropetrovsk, Ukraine
Aim: To compare glycoforms of alpha-acid glycoprotein (AGP) in myeloproliferative neoplasms (MPN) with hepatic lesions. Materials 
and Methods: 110 patients with MPN (31 with polycythaemia vera (PV), 75 with primary myelofibrosis (PMF), 4 with essential throm-
bocythemia (ET)) were examined. 92 patients with atherosclerotic lesions of lower extremities and 10 healthy people comprised the con-
trol. AGP concentration in blood serum was determined by rocket electrophoresis and affinity chromatography. The carbohydrate moiety 
of AGP was studied by lectin blotting with panel comprising eight lectins. The total content of sialic acids and the type of chemical linkage 
with galactose were determined. Results: High-molecular fragments of AGP detected in MPN (MM 68, 84, and 126 kDa) have been 
shown as deriving from leukocytes with glycan moiety identified as neutrophilic component. In MPN with thrombotic complications, AGP 
fragments with MM 84 and 126 kDa prevailed with hypersialic components suggesting the leukocyte component (originated from poly-
morphonuclear neutrophils) as the principal element in the development of thrombotic complications. Furthermore, in MPN with throm-
botic complications, strong direct correlation was established between high levels of lactate dehydrogenase (LDH) and C-reactive protein 
on the one hand and high-molecular fragments of AGP with MM 84 and 126 kDa on the other hand. AGP level depended on primary 
diagnosis: in PV AGP level decreased, PMF (leukocytosis > 20 G/l) was characterized by normal level of AGP due to neutrophilic com-
ponent. In MPN, glycosylation of AGP was reduced due to the N-glycans. Increase in the amount of branched glycans and sialylation 
of AGP in MPN seemed to originate from the high activity of neutrophils. Conclusion: It is determined that the deficiency of platelets and 
leucocytes function plays an important role in progression of myeloproliferative syndrome with myelofibrosis formation.
Key Words: α-acidic glycoprotein, myeloproliferative neoplasms, polymorphonuclear neutrophils, thrombohemorrhagic complications.
The issue concerning pathogenesis of vascular 
complications in patients with myeloproliferative 
neoplasms (MPN) is considered to be extremely 
complicated and requires determination [1, 2]. To-
day it is clearly determined that qualitative deficiency 
of platelets and leukocytes as well as dysfunction 
of vessels’ endothelial tissue play important role 
in progression of myeloproliferative syndrome with 
myelofibrosis formation and severe thrombohemor-
rhagic catastrophes development [3, 4].
It is known that with the help of hemopoiesis hu-
moral factors and growth factors, intercellular space 
of bone marrow matrix regulates the mechanisms 
of adhesion and cells’ migration, controls the pro-
cesses of their differentiation and proliferation, par-
ticipates in collagen exchange.
Myelofibrosis of different intensity is being ob-
served for all MPN and considered to be their integral 
part. The most investigated are changes of microen-
vironment in disease progression. MPN are known 
to be characterized by clonal hyperplasia of dysplastic 
cells, referred to myeloid series [5], in consequence 
develops reactive collagen bone marrow fibrosis with 
deficiency of bone marrow hemopoiesis and appe-
arance of extramedullary hematopoiesis lesions in liver 
and spleen that leads to enlargement of their mass and 
sizes. Processes of inflammation, regeneration, malig-
nant transformation have similar features with changes 
in structure of acute phase abiotic polymerization- 
CRP, ceruloplasmin, α-2-microglobulin, fibrinogen, 
α-acidic glycoprotein. General functional characteris-
tic of proteins in acute phase is their ability to change 
blood coagulation, activate the system of complement 
and kinins, optimize chemotaxis, phagocytosis, as well 
as reactions of microcirculatory bloodstream. Proteins 
of acute phase limit the processes of tissue destruction 
and remove fragments of damaged cells and products 
of their decay from organism.
α-1-Acidic-glycoprotein (AGP) with m.m. 
from 35 to 43 kDa — is one of the least investigated 
component of hemostasis system. It is one of the most 
heterogenetic blood plasma glycoproteins, containing 
five complex type N-glycans, attached to asparagine 
residues. They involve 41–45% of total AGP molecular 
mass. AGP functions depend on carbohydrate com-
ponent structure and its synthesis location. Thus, its 
change in protein structure could have other functional 
characteristics. At change of proteins’ physicochemical 
characteristics, the cytoplasm hydration is observed and 
happens the damage of connection between proteins 
and lipids, which leads to destruction of cells’ membrane 
structures and protein chemical modification.
According to the latest data, AGP is synthesized 
mainly by hepatocytes, the alternative source of AGP 
is blood cells, in particular, activated polymorphonu-
clear neutrophils (PMN), and AGP evolves in response 
for their stimulation. It is determined that AGP in PMN 
Submitted: February 14, 2014.
*Correspondence:  E-mail: dr.nik4@rambler.ru
Abbreviations used: AGP — α-1-acidic-glycoprotein; Con А — con-
canavalines А; ET — essential thrombocythaemia; LABA — Laburnum 
anagiroidus; LcL — Lens culinaris; МАА — Maackia amurensis agglu-
tinin; MPN — myeloproliferative neoplasms; PMF — primary myelofi-
brosis; PMN — polymorphonuclear neutrophils; PV — polycythaemia 
vera; PHA-L — phytohemagglutinin; SNA — Sumbucus nigra.
Exp Oncol 2014
36, 2, 101–106
102 Experimental Oncology 36, 101–106, 2014 (June)
presented via hypersialylated peptide glycoform, con-
tained in secondary neutrophils’ granulas.
In studies, concerning biochemical markers 
of neoplasms, reviewed the diagnostic significance 
of oncofetal proteins the most essential changes 
were defined during proteinoses — cytoplasm pro-
teins closely connected with lipids, forming lipopro-
tein complexes, which are the basis of mitochondria 
membrane, endoplasmatic reticulum, Golgi complex.
The attachment of carbohydrate structures 
to proteins is the most common chemical modifica-
tion. The system of protein-carbohydrate recognition 
is reviewed as additional to genetic code.
Glycosylation, as one of the regulatory mecha-
nisms of cells’ activity, defines intracellular transport 
and processes of intercellular interaction, enhance 
the stability of conformational protein structure. There 
is direct association between glycans’ structure and 
proliferative cell index. As glycosylation occurs more 
than in 50% of proteins, the damage of their structure 
is more widely spread than expression of separate 
oncofetal proteins and, thus, it may define significantly 
earlier and considered as additional to protein — car-
bohydrate recognition system of human genetic code.
More than half of human proteins are proteo-
glycans, mucoproteins, glycoproteins. Glycopro-
teins — structural omponents of cellular membranes, 
collagenic, elastinic, fibrine meshes of matrix are con-
nected with carbohydrate component and called pro-
tein-carbohydrate complexes (PCC). The formation 
of glycane component for surface glycoconjugates 
occurs in the process of obtaining specific characteris-
tics of the cell and has stage-by-stage approach as for 
chronological sequence and for structural aspect.
The biological activity of glycoproteins implements 
only in condition of saving the spatial organization 
of microenvironment.
Glycan part of glycoproteins’ molecules synthesizes 
influenced by cytokines in extracellular matrix. Struc-
tural variety of glycanes depends on tissue specificity 
of genes’ regulation of glycotransferases. Significant 
part of glycoproteins consists of 2-antenna glycans, 
3 and 4-antenna glycans normally synthesized rarely.
Malignant transformation is followed by structure-
functional changes of surface and intracellular glyco-
conjugates, and especially, their carbohydrate com-
ponent. During inflammatory processes the number 
of biantenna glycans increases, during oncotransfor-
mation –preveil three- and tetraantenna carbohydrate 
components. In the presence of changes in confor-
mational structure of glycoproteins, the abnormalities 
in hemostasiological status are developed.
Therefore, the aim of this work was to compare AGP 
glycoforms in case of onco-hematological diseases 
with liver affection and involvement of hematopoiesis 
leukocytic component at MPN, which may provide ad-
ditional information as of its origin for these patients, 
evaluate the type of damaged cells and define their role 
in development of vascular abnormalities at thrombotic 
complications.
MATERIALS AND METHODS
The study was based on analysis of characteris-
tics of clinical presentations among 110 patients with 
MPN. All patient samples were obtained under Re-
search Ethics Board approval with informed consent. 
Clinical-laboratory characteristics: complete blood 
count (hemoglobin, RBC, WBC, differential leuko-
cyte count, platelets), biochemical values, proteins 
of acute phase (C-reactive protein), LDH (lactate de-
hydrogenase), complete hemostasiogramm, results 
of trepan-biopsy samples from iliac bone, abdominal 
ultrasound) had been investigated at the moment 
of initial diagnostics of MPN. Demographic (age, 
sex), anamnestic (concomitant pathologies, episodes 
of vascular complications) and clinical data (general 
condition per WHO scale, presence of spleno- and 
hepatomegaly, plethora signs). Among 110 patients, 
for 31 — polycythaemia vera (PV) was diagnosed, for 
75 — primary myelofibrosis (PMF), for 4 — essential 
thrombocythaemia (ET). Control group consisted 
of 92 patients with atherothrombosis.
For evaluation of probability of thrombotic compli-
cations development, it was defined content in blood 
serum of AGP as risk factor in development of throm-
bohemorrhagic syndrome.
α-Acidic glycoprotein was determined via elec-
troimmunodiffusion in 1% agarose gel, containing 
monospecific polyclonal antiserum to this glycopro-
tein. The control was performed via affinity chroma-
tography on sepharose with immobilized antibodies 
to human AGP [6].
As a source of AGP it was used the pool of 10 blood 
sera from almost healthy donors and analogically pre-
pared blood sera of patients with MPN.
The control of received antibodies specificity was 
performed via immunoelectrophoresis and immu-
noblotting with lectins concanavalines А (Con А) and 
phytohemagglutinin (PHA-L) [7].
For determination the qualitative characteristics 
of composition of AGP carbohydrate part it was applied 
the lectin blot with the use of horseradish peroxide-con-
jugated lectins’ panel [8]: common elder — Sumbucus 
nigra (SNA), bean tree bark — Laburnum anagiroidus 
(LABA) and lentil — Lens culinaris (LcL). Lectin SNA 
is specific to sialic (N-acetylneuraminic) acid, which 
joined to end galactose of glycoprotein carbohydrate 
antenna in position 2→6. Lectin of bean tree bark 
is similar to terminal L-fucosa and is not interacted with 
L-fucosa, which is in the middle of carbohydrate chain.
Lentil lectin is referred to mannosospecific lectin 
and requires the presence of core fucosa as part 
of glycoconjugates.
Almost all studies regarding AGP fucosylation and 
syalilation are related with the use of lectins and anti-
bodies, specific to sialyl — Lewis-antigenes А and Х, 
in particular, substantival composition of fucosa and 
sialic acids as a part of AGP.
The study of syalilation was implemented via deter-
mination of total content of sialic acids, or type of their 
connections with galactose, where 2 types of lectins 
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were used: Maackia amurensis agglutinin (МАА), 
which specifically connected with N-acetylneuraminic 
acid, joined to core galactose in position 2→3 and lectin 
Sumbucus nigra (SNA), interacting with с N-acetyl-
neuraminic acid in position 2 → 6 [9].
RESULTS
Among the patients with MPN prevailed men — 
69 patients. Patients’ age varied from 22 to 75 years.
Negative prognostic factors of MPN course were 
considered significantly enlarged liver and spleen with 
progressing development of myelopoliferative syn-
drome, hyperthrombocytosis, presence of vascular 
complication in anamnesis, concomitant cardio-vascu-
lar pathology, metabolic syndrome, age over 60 years.
The laboratory results for patients with MPN at dise-
ase primary diagnosis indicated in Table 1.
Table 1. Initial values of peripheral blood for patients with MPN
Value
Control 
group
(n = 92)
РMF
(n = 75)
PP
(n = 31)
ET
(n = 9)
Аtero-
sclerosis
(n = 92)
RBC (T/l) 4.10 ± 0.8 6.17 ± 1.98 6.73 ± 1.52 5.6 ± 1.34 4.27 ± 0.9
Hemoglobin 
(g/l)
130.4 ± 23.6 150.4 ± 38.3 176.1 ± 33.0 138.5 ± 34.4 134.8 ± 27.9
Platelets (g/l) 235.9 ± 97.3 651.3 ± 41.9 448.7 ± 76.3 875.20 ± 143.1 251.8 ± 103.0
WBC (g/l) 7.0 ± 2.2 20.34 ± 12.9 11.6 ± 5.8 10.0 ± 3.2 9.01 ± 1.9
LDH value for patients with varied from 250 g/l till 
640 g/l (at average — 434 g/l, in control group — 
265 g/l). CRP level at high LDH level the qualitative 
test showed ++++.
At PMF and essential thrombocythemia (ET) 
in bone trepan biopsy samples prevailed reticular fi-
brosis with hyperplasia of megakaryocytic lineage, and 
at PV — reactive changes in bone marrow characte-
rized by increased erythroid and myeloid proliferations.
Phenolic extract of blood serum of patient with MPN 
contained AGP polypeptides with m.m. 42; 68; 84 and 
126 kDa (Fig. 1).
a b
Fig. 1. Crossed affine immunoelectrophoresis with the use 
of antiserum to human blood serum: a — serum of patients with 
MPN; b — blood serum of donors. → direction of electrophoresis 
(cathode — anode)
The control of electrophoresis results were per-
formed via immunoblotting (Fig. 2). Upon that, the pro-
tein with molecular mass 42 kDa prevailed, which cor-
responds to plasma AGP of hepatic origin. Additionally 
high-molecular zones corresponding to molecular 
masses 68; 84 and 126 kD were defined, which may 
be determined by the presence of dimeric and trimeric 
AGP forms. It is possible that high-molecular AGP may 
have neutrophilic origin.
126 kDa —
— 97,4 kDa
— 67 kDa
— 45 kDa42 kDa —
86 kDa —
68 kDa —
a b
Fig. 2. Blotogram (a) and electrophoretogram (b) of frac-
tions, received via hydrophobic extraction by phenylic acid: 
1 — phenylic extract of the blood sera pool of patients with MPN; 
2 — phenylic extract of the blood sera pool of healthy donors; 
3 — marker protein
On Fig. 3 the study results of AGP fragments with 
m.m. 68, 86,126 kDa are presented.
a b c d
— 37 kDa
— 50 kDa
225 kDa —
126 kDa —
71–90 kDa —
66–70 kDa —
50 kDa —
41 kDa —
1 2 3 4 1 2 3 4
Fig. 3. Immunoblotting of AGP fraction, received via afinne 
chromatography on immunoadsorbent: a — interaction with anti-
bodies to human AGP; b — interaction with antibodies to human 
IgG; c — marker protein; d — interaction with antibodies to crawl 
IgG. 1 — standard AGP solution; 2 — serum of healthy donor; 
3 — AGP, received from the pool of healthy donors’ blood sera; 
4 — AGP, received from the pool of patients with MPN blood sera
Staining in zones 225; 110; 66–70 kDa corresponds 
to AGP complexes with ligands, which is transported 
(sialic acids).
There are single evidences in literature [10] that 
AGP with molecular mass 50–60 kDa synthesized 
by secondary granules of PMN and discharged in plas-
ma at their stimulation, while plasma AGP, synthesized 
by hepatocytes, has molecular mass 42–45 kDa. PMN-
AGP is hypersialylated glycoform of AGP.
Neutrophilic leukocytes at various MPN forms re-
ferred to several clones, which may indicate different 
degree of their maturity and activity.
At interaction of AGP with Con A 3 peak point ap-
pear, PHA-L two peak point appear (Fig. 4):  AGP-1а — 
fraction, which is not interlinked and AGP-2а — frac-
tion, which is interlinked with lectin.
a b
3
2
1 2a
1a
Fig. 4. Crossed affine immunoelectrophoresis of AGP blood 
serum of healthy donors. → direction of electrophoresis 
( cathode — anode)
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Fraction AGP-1а contains AGP glycoforms only with 
biantenna glycans, AGP-2а — glycoforms, containing 
polyantenna N-glycans.
According to our results, the content of AGP in healthy 
donors’ blood serum varied from 0.54 to 0.84 g/l and 
implied in average 0.77 ± 0.026 g/l. It coincides the data 
of other studies, where AGP varies from 0.55 to 1.4 g/l.
Data, presented in Table 2, coincides with other 
studies results [11], which related to affinity to con-
canavalin (Соn А) [12] and phytohemagglutinin РНА-L.
Table 2. Correlation of lectin-binding AGP fractions in healthy donors 
blood serum
Correlation of Con A-binding 
AGP fractions, %
Correlation PHA-L
Binding AGP fractions, %
AGP-1 AGP-2 AGP-3 AGP-1а AGP-2а
42.54 ± 0.98 49.32 ± 0.77 8.15 ± 0.38 13.44 ± 0.77 86.56 ± 0.77
The level of expression and microheteroge-
neity of α-acidic glycoprotein at MPN. In patients 
with MPN observed unclear separation of AGP frac-
tions, which are not interlinked with PHA-L (Fig. 5). 
These qualitative characteristics of lectin-binding 
ability of AGP may indicate on more essential ab-
normalities in glycated AGP, which is directly re-
lated to glycoprotein fucosylation and syalilation.
a b
2a
1a
2a
1a
Fig. 5. Crossed affine immunoelectrophoresis of AGP blood 
serum for human normal (a) and in MPN (b): 1а, 2а — fractions 
of AGP-1а, AGP-2а at interaction with PHA-L.  → — direction 
of electrophoresis (cathode — anode)
The investigation of AGP concentration in blood 
serum in patients with MPN. The AGP concentration 
in blood serum in patients with MPN firmly decreases 
at PV till 0.60 ± 0.025 g/l, maybe due to decrease 
of AGP production by hepatocytes.
During PMF the AGP content in blood serum is just 
higher the values of patients from control group — 
0.85 ± 0.017 g/l. It may be the consequence of in-
volvement in the process the leukocytic component, 
as AGP is synthesized also by PMN in response for 
their stimulation [12], that leads to increase of AGP 
and PMF development.
The increase of AGP level is observed for patients 
with MPN, who had thrombotic complications after 
3–4 weeks since vascular catastrophe and implies 
0.97 ± 0.03 g/l (р < 0.01). Taking into account lectins’ 
specificity, it may affirm, that absolute content of bi-
antenna glycans increase at thrombotic complications 
or the possibility of their occurrence. It is confirmed 
by the increase of values for acute phase proteins.
According to lectin blot as well as lectins’ specifi-
city, it may conclude as of the presence in the content 
of AGP blood serum for healthy donors core and ter-
minal fucosa and sialic acids in position 2→6, as indi-
cated by intensive electrophoretic component during 
interaction of AGP with LcL (Fig. 6).
AGP (m.m. 41–42 kDa)
a b c
Fig. 6. Lectin-blot analysis of human AGP blood serum: a — in-
teraction with SNA, b — interaction with LABA, c — interaction 
with LcL
Thus, taking into account different variants of lectin 
analysis, it was proved the microheterogeneity of AGP 
blood serum for healthy donors, which is characteri-
zed by: 1 — the presence of several AGP forms with 
different grades of glycans’ branching: bi-, tri- and 
tetraantenna; 2 — different glycans’ affinity to lectins 
Con А and PHA-L: interaction AGP with Con A showed 
by development of three glycoforms, at interaction with 
PHA-L — two; 3 — presence in the content of some 
AGP glycoforms terminal and core fucosa, as well 
as N-acetylneuraminic acid in position 2→6.
Level of expression and α-acidic glycoprotein 
microheterogeneity in blood serum for patients 
with MPN. According to lectinenzyme method 
of analy sis, with the use of lectin SNA, wide variation 
of sialic acids content in AGP is registered.
At MPN, it is firmly decreases the binding degree 
of AGP carbohydrate component with all lectins, 
which proves the decrease of glycoprotein’s glyca-
tion. (Table 3, Fig. 7), consequently, the change 
of PMN qualitative characteristics with distur-
bance of activity due to different maturity degree.
0
20
40
60
80
100
120
140
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%
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PV
PMF
Fig. 7. Degree of AGP binding with lectins for patients with MPN, 
who have atherothrombosis
AGP binding with LCA increased at PMF for those 
patients, who recovered from thrombotic complica-
tions, which indicates on increase of cortex flucosation 
processes. Comparison of AGP binding degree with 
LCA and AAL demonstrated that the first lectin had 
less affinity to AGP than AAL. Enchancement of AAL 
and AGP interaction may be related to appearance 
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of posicia а 1→3 fucosa in the content of AGP oliga-
saccharide chain.
Table 3. Nature of change of AGP carbohydrate component in patients 
with MPN
Parameters Normal PV PMF
Compli-
cated 
MPN
Athero-
thrombo-
sis
AGP level, g/l 0.77 ± 0.026 0.60 ± 0.025 0.85 ± 0.01 0.97 ± 0.03 1.1 ± 0.05
AGP + Con A, % 100 80–90 100–110 120–130 130–150
AGP + LCA, % 100 80–90 120–130 150–170 150–170
AGP + AAL, % 100 75–80 120–130 150–170 100
AGP + LABA, % 100 75–80 120–130 120–130 90–100
AGP + SNA, % 100 80–90 100–120 150–170 100–120
AGP + MAA, % 100 70–80 100–120 120–130 90–100
AGP + WGA, % 100 80–90 100–120 100–120 90–100
The interaction of AGP with lectin LABA disco-
vered the presence of terminal fucosa in N-glycans. 
According to our data, the AGP binding degree with 
LABA increases at PMF, probably, due to neutrophilic 
component of leukocytes. For the rest groups, this 
index was almost similar to normal ranges.
Thus, the appearance of terminal fucosa in glycans 
at AGP and LABA interaction may serve as additional 
criterion for diagnosing and progression of myelopo-
liferative processes for patients with MPN.
AGP binding degree sialospecific lectin SNA-1 in-
creases at MPN. This lectin interacts with sialic acids 
of biantenna N-glycans and our data proved that for 
patients with MPN, who had thrombotic complica-
tions, increase the content of biantenna glycans with 
terminal N-acetylneuraminic acid. It coincides with the 
results of AGP interaction with another sialospecific 
lectin — МАА-ІІ, affinated to sialic acids of polyantenna 
glycans, which connected with glycosidic binding. 
The binding with MАА-ІІ increased at PМF due to leu-
kocytic component; decreased at PV.
At AGP interaction with WGA, which is also specific 
to N-acetylneuraminic acid, increase of interaction 
defined for patients with PMF and myelopoliferative 
syndrome, mostly, — for patients, who had vascular 
complications. Lectin of wheat germs may be bound 
with polyantenna structures, increase of mentioned 
lectin’s binding degree with AGP carbohydrate compo-
nent regarding SNA-1 indicates on increase of polyan-
tenna glycans in glycoprotein content. When compared 
the AGP binding with Соn А and WGA, it was discovered 
that decrease of interaction with Соn А at PFM, which 
proved the increase of N-glycans branching in glyco-
protein content at MPN and indicated on the existence 
of malignantly transformed leukocyte clone. At normal 
ranges, AGP plasma contains insignificant number 
of such structures, and they are more characteristic 
for fetal alfa-acidic glycoprotein [11] at malignant cells’ 
transformation. Their development may serve as ad-
ditional marker at diagnostics of myelopoliferative 
neoplasma and be the criterion for myelopoliferative 
disease progression.
In conclusion, defined high-molecular AGP frag-
ments with m.m. 68,84 and 126 kDa for patients with 
MPN are leukocytic derivatives, as AGP is proved 
to be synthesized by neutrophils,unlike its analog 
of hepatocytic origin, has heavy molecular mass due 
to their different degree of maturity and activity. High-
molecular AGP fragments at MPN consist of hypersialic 
components and polyantenna fucosated glycans. AGP 
binding with lectins Соn А and РНА in cohort of pa-
tients with MPN didn’t demonstrated accurate data 
as of presence of bi- and polyantenna glycans, which 
indicates on change of AGP plasma glycan compo-
nent due to neutrohilic component. In blood serum 
of patients with MPN, who had thrombotic complica-
tions, direct correlation between high LDH and CRP 
with high-molecular AGP fragments (m.m. 68, 84 and 
126 kDa) was established. Levels of AGP in patients 
with PV are decreased due to development of fibrotic 
processes in liver and abnormality of its synthesis 
by hepatocytes. In patients with PMF at leukocyto-
sis more 20 G/l normal AGP content was registered 
in blood serum, which determined by neutrophilic 
component. Binding of AGP biantenna glycans with 
lectins Соn А at MPN corresponded to control mea-
sure, and with other lectins’ groups decreased, which 
indicated on decrease of AGP glycation due to N-gly-
cans. Increase of glycans with branching and AGP 
syalilation for patients with MPN occurred due to high 
neutrophils’ activity. AGP blood serum of patients with 
MPN was defined to contain N-glycans with terminal 
remains а posicia 1→2 of fucosa both at normal and 
in at pathology, and also N-glycans flucosation de-
gree depends on type of pathological process and 
may serve additional criterion in MPN diagnostics. 
Multidirectional changes of AGP N-glycans syalilation 
in blood serum of patients depend on pathology type: 
at atherothrombosis observed the increase of syalila-
tion on а 2→6N-acetylneuraminic acid remains, and 
at MPN the syalilation degree increases due to 2→6 and 
2→3 N-acetylneuraminic acid remains. In patients with 
thrombotic complications at MPN prevailed fragments 
with m.m. 84 and 126 kDa, mainly with hypersyalic 
components, that characterize leukocytic component 
(polymorphonuclear neutrophil) as the main activating 
element in development of thrombotic complications.
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